"Ovarian Cancer Treatment"
Drug Updates

Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial

 Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and prevention of cancer, today announced that treatment has commenced for the fourth patient in the ongoing Phase 1 clinical trial of its novel chimeric antigen receptor T-cell (CAR-T) therapy for ovarian cancer. The study is being conducted through a research partnership […]

Digital Health News

Reveal HealthTech Partners with CancerX and the CancerX Accelerator Program to Drive Cancer Innovation

Reveal HealthTech, a leading healthcare technology company, today announced a new partnership with CancerX, a public-private partnership to accelerate cancer innovation. Through this partnership, Reveal HealthTech will join the CancerX community and serve as a Champion within the CancerX Accelerator.  Reveal HealthTech is excited to lend its expertise, services, and mentorship to all members of the […]